FdaApplication
ANDA 075117
Identifiers
- fda_app_no: ANDA075117
Properties
| Property | Value |
|---|---|
| applicant_name | CONCORDIA PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2000-12-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORAPRED | PREDNISOLONE SODIUM PHOSPHATE | EQ 15MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL |
1 product